Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting

18d ago

MIST

PremiumPress Releases

Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences

25d ago

MIST

PremiumCompany Announcements

Milestone’s Etripamil Aims to Revolutionize PSVT Treatment

29d ago

MIST

PremiumCompany Announcements

Milestone Pharmaceuticals Advances Etripamil Development

1M ago

MIST

PremiumPress Releases

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update

1M ago

MIST

More MIST News >

MIST News on the Web

2024-04-17

Milestone® Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium

Yahoo Finance

Neutral

2024-04-09

Milestone’s Etripamil Shows Promise in Self-Managed PSVT Treatment

TipRanks News

Neutral

2024-04-08

Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting

Yahoo Finance

Neutral

2024-04-03

Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference

Yahoo Finance

Neutral

2024-04-01

Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences

Yahoo Finance

Neutral

2024-03-28

Milestone’s Etripamil Aims to Revolutionize PSVT Treatment

TipRanks News

Neutral

2024-03-28

Milestone Pharmaceuticals Announces Resubmission of New Drug Application for Etripamil for Treatment in Paroxysmal Supraventricular Tachycardia

Yahoo Finance

Neutral

2024-03-22

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Milestone Pharmaceuticals (MIST)

TipRanks News

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MIST’s Media Buzz Sentiment?

Currently, no data Available

What is MIST’s weekly average amount of articles?

Currently, no data Available

What is MIST’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

TAKTakeda Pharmaceutical Company

NBIXNeurocrine

AMEDAmedisys

MORFMorphic Holding

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing